Skip to main content
Erschienen in:

29.09.2018 | Insomnie | Zertifizierte Fortbildung

Schlaf-Wach-Störungen

Insomnie bei neurologischen Erkrankungen

verfasst von: Prof. Dr. med. Geert Mayer

Erschienen in: DNP – Die Neurologie & Psychiatrie | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Zusammenfassung

Schlaf-Wach-Störungen können Vorboten von neurologischen Erkrankungen oder komorbide Störungen sein. Bei neurologischen Erkrankungen ist die Prävalenz sehr hoch. Lesen Sie hier, worauf es bei Insomnien im Zusammenhang mit Demenz, Epilepsie, Multipler Sklerose, Morbus Parkinson und Schlaganfall ankommt.
Literatur
1.
Zurück zum Zitat Bassetti CL, Ferini-Strambi L, Brown S, Adamantidis A, Benedetti F et al. Neurology and psychiatry: waking up to opportunities of sleep: State of the art and clinical/research priorities for the next decade. Eur J Neurol 2015; 22(10):1337–54CrossRef Bassetti CL, Ferini-Strambi L, Brown S, Adamantidis A, Benedetti F et al. Neurology and psychiatry: waking up to opportunities of sleep: State of the art and clinical/research priorities for the next decade. Eur J Neurol 2015; 22(10):1337–54CrossRef
2.
Zurück zum Zitat Laugsand LE, Vatten LJ, Platou C, Janszky I. Insomnia and the risk of acute myocardial infarction: a population study. Circulation 2011; 124:2073–81CrossRef Laugsand LE, Vatten LJ, Platou C, Janszky I. Insomnia and the risk of acute myocardial infarction: a population study. Circulation 2011; 124:2073–81CrossRef
3.
Zurück zum Zitat Chandola T, Ferrie JE, Perski A, Akbaraly T, Marmot MG. The effect of short sleep duration on coronary heart disease risk is greatest among those with sleep disturbance: a prospective study from the Whitehall II cohort. Sleep 2010; 33:739–44CrossRef Chandola T, Ferrie JE, Perski A, Akbaraly T, Marmot MG. The effect of short sleep duration on coronary heart disease risk is greatest among those with sleep disturbance: a prospective study from the Whitehall II cohort. Sleep 2010; 33:739–44CrossRef
4.
Zurück zum Zitat Morphy H, Dunn KM, Lewis M, Boardman HF, Croft PR. Epidemiology of insomnia: a longitudinal study in a UK population. Sleep 2007; 30:274–80PubMed Morphy H, Dunn KM, Lewis M, Boardman HF, Croft PR. Epidemiology of insomnia: a longitudinal study in a UK population. Sleep 2007; 30:274–80PubMed
5.
Zurück zum Zitat DGN Leitlinie Insomnie; AWMF Registriernr. 030-045 DGN Leitlinie Insomnie; AWMF Registriernr. 030-045
6.
Zurück zum Zitat Riemann D, Baglioni C, Bassetti C et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res 2017; 26:675–700CrossRef Riemann D, Baglioni C, Bassetti C et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res 2017; 26:675–700CrossRef
7.
Zurück zum Zitat WHO. Kapitel V—F51.0 Insomnien. In: ICD-10 (international statistical classification of diseases and related health problems). WHO, Genf, 1992 WHO. Kapitel V—F51.0 Insomnien. In: ICD-10 (international statistical classification of diseases and related health problems). WHO, Genf, 1992
8.
Zurück zum Zitat American Academy of Sleep Medicine (Hrsg) ICSD-3 (International Classification of Sleep ICSD-2 Disorders). American Association of Sleep Medicine, Darien. 2014 American Academy of Sleep Medicine (Hrsg) ICSD-3 (International Classification of Sleep ICSD-2 Disorders). American Association of Sleep Medicine, Darien. 2014
9.
Zurück zum Zitat Riemann D et al. Leitlinie S3 „Nicht erholsamer Schlaf/Schlafstörungen Kapitel Insomnie bei Erwachsenen“. Somnologie 2017; 21:2–44CrossRef Riemann D et al. Leitlinie S3 „Nicht erholsamer Schlaf/Schlafstörungen Kapitel Insomnie bei Erwachsenen“. Somnologie 2017; 21:2–44CrossRef
10.
Zurück zum Zitat Morin CM, Drake CL, Harvey AG et al. Insomnia disorder. Nature Reviews 2015; 1:1–18 Morin CM, Drake CL, Harvey AG et al. Insomnia disorder. Nature Reviews 2015; 1:1–18
11.
Zurück zum Zitat Koenigs M, Holliday J, Solono J et al. Left dorsomedial frontal brain damage is associated with insomnia. J Neurosci 2010; 30:16041–3CrossRef Koenigs M, Holliday J, Solono J et al. Left dorsomedial frontal brain damage is associated with insomnia. J Neurosci 2010; 30:16041–3CrossRef
12.
Zurück zum Zitat Spiegelhalder K, Regen W, Feige B et al. Increased EEG sigma and beta power during NREM sleep in primary insomnia. Biol Psychol 2012; 91:329–33CrossRef Spiegelhalder K, Regen W, Feige B et al. Increased EEG sigma and beta power during NREM sleep in primary insomnia. Biol Psychol 2012; 91:329–33CrossRef
13.
Zurück zum Zitat Baglioni C, Regen W, Teghen A et al. Sleep changes in the disorderof insomnia: a meta-analysis of polysomnographic studies. Sleep Med Rev 2014; 18:195–213CrossRef Baglioni C, Regen W, Teghen A et al. Sleep changes in the disorderof insomnia: a meta-analysis of polysomnographic studies. Sleep Med Rev 2014; 18:195–213CrossRef
14.
Zurück zum Zitat Alibhai FJ, LaMarre J, Reitz CJ, Tsimakouridze EV, Kroetsch JT, Bolz SS, Shulman A, Steinberg S, Burris TP, Oudit GY, Martino TA. Disrupting the key circadian regulator CLOCK leads to age-dependent cardiovascular disease. J Mol Cell Cardiol 2017; 105:24–37CrossRef Alibhai FJ, LaMarre J, Reitz CJ, Tsimakouridze EV, Kroetsch JT, Bolz SS, Shulman A, Steinberg S, Burris TP, Oudit GY, Martino TA. Disrupting the key circadian regulator CLOCK leads to age-dependent cardiovascular disease. J Mol Cell Cardiol 2017; 105:24–37CrossRef
15.
Zurück zum Zitat Potvin O, Lorrain D, Forget H, Dubé M, Grenier S, Préville M et al. Sleep quality and 1-year incident cognitive impairment in community-dwelling older adults. Sleep 2012; 35:491–9CrossRef Potvin O, Lorrain D, Forget H, Dubé M, Grenier S, Préville M et al. Sleep quality and 1-year incident cognitive impairment in community-dwelling older adults. Sleep 2012; 35:491–9CrossRef
16.
Zurück zum Zitat Burke SL, Maramaldi P, Cadet T, Kukull W. Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer’s disease: dementia. Int Psychogeriatr 2016; 28:1409–24CrossRef Burke SL, Maramaldi P, Cadet T, Kukull W. Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer’s disease: dementia. Int Psychogeriatr 2016; 28:1409–24CrossRef
17.
Zurück zum Zitat Branger P, Arenaza-Urquijo EM, Tomadesso C, Mézenge F, André C, de Flores R et al. Relationships between sleep quality and brain volume, metabolism, and amyloid deposition in late adulthood. Neurobiol Aging 2016; 41:107–14CrossRef Branger P, Arenaza-Urquijo EM, Tomadesso C, Mézenge F, André C, de Flores R et al. Relationships between sleep quality and brain volume, metabolism, and amyloid deposition in late adulthood. Neurobiol Aging 2016; 41:107–14CrossRef
18.
Zurück zum Zitat Guarnieri B, Adorni F, Musicco M, Appollonio I, Bonanni E et al. Prevalence of Sleep Disturbances in Mild Cognitive Impairment and Dementing Disorders: A Multicenter Italian Clinical Cross-Sectional Study on 431 Patients. Dement Geriatr Cogn Disord 2012; 33:50–8CrossRef Guarnieri B, Adorni F, Musicco M, Appollonio I, Bonanni E et al. Prevalence of Sleep Disturbances in Mild Cognitive Impairment and Dementing Disorders: A Multicenter Italian Clinical Cross-Sectional Study on 431 Patients. Dement Geriatr Cogn Disord 2012; 33:50–8CrossRef
19.
Zurück zum Zitat McCleery J, Cohen DA, Sharpley AL. Pharmacotherapies for sleep disturbances in dementia. Cochrane Database Syst Rev. 2016; 11:CD009178PubMed McCleery J, Cohen DA, Sharpley AL. Pharmacotherapies for sleep disturbances in dementia. Cochrane Database Syst Rev. 2016; 11:CD009178PubMed
20.
Zurück zum Zitat Wilt TJ, MacDonald R, Brasure M, Olson CM, Carlyle M et al. Pharmacologic Treatment of Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians. Ann Intern Med 2016; 165(2):103–12CrossRef Wilt TJ, MacDonald R, Brasure M, Olson CM, Carlyle M et al. Pharmacologic Treatment of Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians. Ann Intern Med 2016; 165(2):103–12CrossRef
21.
Zurück zum Zitat van Maanen A, Meijer AM, van der Heijden KB, Oort FJ. The effects of light therapy on sleep problems: A systematic review and meta-analysis. Sleep Med Rev 2016; 29:52–62CrossRef van Maanen A, Meijer AM, van der Heijden KB, Oort FJ. The effects of light therapy on sleep problems: A systematic review and meta-analysis. Sleep Med Rev 2016; 29:52–62CrossRef
22.
Zurück zum Zitat Vendrame M, Yang B, Jackson S, Auerbach SH. Insomnia and epilepsy: a questionnaire-based study. J Clin Sleep Med 2013; 9(2):141–6PubMedPubMedCentral Vendrame M, Yang B, Jackson S, Auerbach SH. Insomnia and epilepsy: a questionnaire-based study. J Clin Sleep Med 2013; 9(2):141–6PubMedPubMedCentral
23.
Zurück zum Zitat Macedo PJOM, Oliveira PS, Foldvary-Schaefer N, Gomes MDM. Insomnia in people with epilepsy: A review of insomnia prevalence, risk factors and associations with epilepsy-related factors. Epilepsy Res 2017; 135:158–67CrossRef Macedo PJOM, Oliveira PS, Foldvary-Schaefer N, Gomes MDM. Insomnia in people with epilepsy: A review of insomnia prevalence, risk factors and associations with epilepsy-related factors. Epilepsy Res 2017; 135:158–67CrossRef
24.
Zurück zum Zitat Yazdi Z, Sadeghniiat-Haghighi K, Naimian S, Zohal MA, Ghaniri M. Prevalence of Sleep Disorders and their Effects on Sleep Quality in Epileptic Patients. Basic and Clinical Neuroscience 2013; 4:36–41PubMedPubMedCentral Yazdi Z, Sadeghniiat-Haghighi K, Naimian S, Zohal MA, Ghaniri M. Prevalence of Sleep Disorders and their Effects on Sleep Quality in Epileptic Patients. Basic and Clinical Neuroscience 2013; 4:36–41PubMedPubMedCentral
25.
Zurück zum Zitat Yang KI, Grigg-Damberger M, Andrews N, O’Rourke C, Bena J et al. Severity of self-reported insomnia in adults with epilepsy is related to comorbid medical disorders and depressive symptoms. Epilepsy & Behavior 2016; 60:27–32CrossRef Yang KI, Grigg-Damberger M, Andrews N, O’Rourke C, Bena J et al. Severity of self-reported insomnia in adults with epilepsy is related to comorbid medical disorders and depressive symptoms. Epilepsy & Behavior 2016; 60:27–32CrossRef
26.
Zurück zum Zitat Brass SD, Li CS, Auerbach S. The underdiagnosis of sleep disorders in patients with multiple sclerosis. J Clin Sleep Med 2014; 10(9):1025–31PubMedPubMedCentral Brass SD, Li CS, Auerbach S. The underdiagnosis of sleep disorders in patients with multiple sclerosis. J Clin Sleep Med 2014; 10(9):1025–31PubMedPubMedCentral
27.
Zurück zum Zitat Veauthier C, Gaede G, Radbruch H, Sieb J-P, Wernecke K-D, Paul F. Periodic limb movements during REM sleep in multiple sclerosis: a previously undescribed entity. Neuropsychiatr Dis Treat 2015; 11:2323CrossRef Veauthier C, Gaede G, Radbruch H, Sieb J-P, Wernecke K-D, Paul F. Periodic limb movements during REM sleep in multiple sclerosis: a previously undescribed entity. Neuropsychiatr Dis Treat 2015; 11:2323CrossRef
28.
Zurück zum Zitat Greim B, Benecke R, Zettl UK. Qualitative and quantitative assessment of fatigue in multiple sclerosis (MS). J Neurol 2007; 254(S2):58–64 Greim B, Benecke R, Zettl UK. Qualitative and quantitative assessment of fatigue in multiple sclerosis (MS). J Neurol 2007; 254(S2):58–64
29.
Zurück zum Zitat Veauthier et al. The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis related fatigue. The EPMA Journal 2016; 7:25CrossRef Veauthier et al. The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis related fatigue. The EPMA Journal 2016; 7:25CrossRef
30.
Zurück zum Zitat Baron KG, Corden M, Jin L, Mohr DC. Impact of psychotherapy on insomnia symptoms in patients with depression and multiple sclerosis. J Behav Med 2011; 34(2):92–101CrossRef Baron KG, Corden M, Jin L, Mohr DC. Impact of psychotherapy on insomnia symptoms in patients with depression and multiple sclerosis. J Behav Med 2011; 34(2):92–101CrossRef
31.
Zurück zum Zitat Asano M, Finlayson ML. Meta-analysis of three different types of fatigue management interventions for people with multiple sclerosis: exercise, education, and medication. Mult Scler Int 2014; 2014:1–12CrossRef Asano M, Finlayson ML. Meta-analysis of three different types of fatigue management interventions for people with multiple sclerosis: exercise, education, and medication. Mult Scler Int 2014; 2014:1–12CrossRef
32.
Zurück zum Zitat Ylikoski A, Martikainen K, Partinen M. Parkinson’s disease and chronic insomnia disorder. sleepmedicine 2015; 16(suppl 1):S248 Ylikoski A, Martikainen K, Partinen M. Parkinson’s disease and chronic insomnia disorder. sleepmedicine 2015; 16(suppl 1):S248
33.
Zurück zum Zitat Högl B, Arnulf I, Comella C, Ferreira J, Iranzo A et al. Scales to assess sleep impairment in Parkinson’s disease: Critique and recommendations. Mov Disord 2010;;25(16):2704–16CrossRef Högl B, Arnulf I, Comella C, Ferreira J, Iranzo A et al. Scales to assess sleep impairment in Parkinson’s disease: Critique and recommendations. Mov Disord 2010;;25(16):2704–16CrossRef
34.
Zurück zum Zitat Ylikoski A, Martikainen K, Sieminski M, Partinen M. Parkinson’s disease and insomnia. Neurol Sci 2015; 36(11):2003–10CrossRef Ylikoski A, Martikainen K, Sieminski M, Partinen M. Parkinson’s disease and insomnia. Neurol Sci 2015; 36(11):2003–10CrossRef
35.
Zurück zum Zitat Hsiao YH, Chen YT, Tseng CM, Wu LA, Perng DW et al. Sleep disorders and an increased risk of Parkinson’s disease in individuals with non-apnea sleep disorders: a population-based cohort study. J Sleep Res 2017; 26(5):623–8CrossRef Hsiao YH, Chen YT, Tseng CM, Wu LA, Perng DW et al. Sleep disorders and an increased risk of Parkinson’s disease in individuals with non-apnea sleep disorders: a population-based cohort study. J Sleep Res 2017; 26(5):623–8CrossRef
36.
Zurück zum Zitat Tholfsen LK, Larsen JP, Schulz J, Tysnes OB, Gjerstad MD. Changes in insomnia subtypes in early Parkinson disease. Neurology 2017; 88(4):352–8CrossRef Tholfsen LK, Larsen JP, Schulz J, Tysnes OB, Gjerstad MD. Changes in insomnia subtypes in early Parkinson disease. Neurology 2017; 88(4):352–8CrossRef
37.
Zurück zum Zitat Hu K, van Hilten JJ, Marinus J. The course of insomnia in Parkinson’s disease. Parkinsonism Relat Disord 2016; 33:51–7CrossRef Hu K, van Hilten JJ, Marinus J. The course of insomnia in Parkinson’s disease. Parkinsonism Relat Disord 2016; 33:51–7CrossRef
38.
Zurück zum Zitat Pont-Sunyer C, Iranzo A, Gaig C, Fernández-Arcos A, Vilas D et al. Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers. PLoS One 2015; 10(7): e0132368CrossRef Pont-Sunyer C, Iranzo A, Gaig C, Fernández-Arcos A, Vilas D et al. Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers. PLoS One 2015; 10(7): e0132368CrossRef
39.
Zurück zum Zitat Menza M, Dobkin RD, Marin H, Gara M, Bienfait K, Dicke A, Comella CL, Cantor C, Hyer L. Treatment of Insomnia in Parkinson’s Disease: A controlled trial of eszopiclone and placebo. Mov Disord 2010; 25(11):1708–14CrossRef Menza M, Dobkin RD, Marin H, Gara M, Bienfait K, Dicke A, Comella CL, Cantor C, Hyer L. Treatment of Insomnia in Parkinson’s Disease: A controlled trial of eszopiclone and placebo. Mov Disord 2010; 25(11):1708–14CrossRef
40.
Zurück zum Zitat Rodrigues TM, Castro Caldas A, Ferreira JJ. Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson’s disease: Systematic review and meta-analysis. Parkinsonism Relat Disord 2016; 27:25–34CrossRef Rodrigues TM, Castro Caldas A, Ferreira JJ. Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson’s disease: Systematic review and meta-analysis. Parkinsonism Relat Disord 2016; 27:25–34CrossRef
41.
Zurück zum Zitat Leeman AL, O’Neill CJ, Nicholson PW et al. Parkinson’s disease in the elderly: response to and optimal spacing of night time dosing with levodopa. Br J Clin Pharmacol 1987; 24(5):637–43CrossRef Leeman AL, O’Neill CJ, Nicholson PW et al. Parkinson’s disease in the elderly: response to and optimal spacing of night time dosing with levodopa. Br J Clin Pharmacol 1987; 24(5):637–43CrossRef
42.
Zurück zum Zitat Iranzo A, Valldeoriola F, Santamaría J, Tolosa E, Rumià J. Sleep symptoms and polysomnographic architecture in advanced Parkinson’s disease after chronic bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002; 72(5):661–4CrossRef Iranzo A, Valldeoriola F, Santamaría J, Tolosa E, Rumià J. Sleep symptoms and polysomnographic architecture in advanced Parkinson’s disease after chronic bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002; 72(5):661–4CrossRef
43.
Zurück zum Zitat Humbert M, Findley J, Hernandez-Con M, Chahine LM. Cognitive behavioral therapy for insomnia in Parkinson’s disease: a case series. NPJ Parkinsons Dis 2017; 3:25CrossRef Humbert M, Findley J, Hernandez-Con M, Chahine LM. Cognitive behavioral therapy for insomnia in Parkinson’s disease: a case series. NPJ Parkinsons Dis 2017; 3:25CrossRef
44.
Zurück zum Zitat Patel S, Ojo O, Genc G, Oravivattanakul S, Huo Y et al. A Computerized Cognitive behavioral therapy Randomized, Controlled, pilot trial for insomnia in Parkinson Disease. J Clin Movement Disorders 2017; 4:16CrossRef Patel S, Ojo O, Genc G, Oravivattanakul S, Huo Y et al. A Computerized Cognitive behavioral therapy Randomized, Controlled, pilot trial for insomnia in Parkinson Disease. J Clin Movement Disorders 2017; 4:16CrossRef
45.
Zurück zum Zitat Fernández-Pajarín G, Sesar Á, Ares B, Castro A. Evaluating the Efficacy of Nocturnal Continuous Subcutaneous Apomorphine Infusion in Sleep Disorders in Advanced Parkinson’s Disease: The APO-NIGHT Study. J Parkinsons Dis 2016; 6(4):787–92CrossRef Fernández-Pajarín G, Sesar Á, Ares B, Castro A. Evaluating the Efficacy of Nocturnal Continuous Subcutaneous Apomorphine Infusion in Sleep Disorders in Advanced Parkinson’s Disease: The APO-NIGHT Study. J Parkinsons Dis 2016; 6(4):787–92CrossRef
46.
Zurück zum Zitat Leppävuori A, Pohjasvaara T, Vataja R, Kaste M, Erkinjuntti T. Insomnia in ischemic stroke patients. Cerebrovasc Dis 2002; 14:90–7CrossRef Leppävuori A, Pohjasvaara T, Vataja R, Kaste M, Erkinjuntti T. Insomnia in ischemic stroke patients. Cerebrovasc Dis 2002; 14:90–7CrossRef
47.
Zurück zum Zitat Baglioni C, Nissen C, Schweinoch A, Riemann D, Spiegelhalder K, Berger M et al. Polysomnographic Characteristics of Sleep in Stroke: A Systematic Review and Meta-Analysis. PLoS ONE 2016; 11(3):e0148496CrossRef Baglioni C, Nissen C, Schweinoch A, Riemann D, Spiegelhalder K, Berger M et al. Polysomnographic Characteristics of Sleep in Stroke: A Systematic Review and Meta-Analysis. PLoS ONE 2016; 11(3):e0148496CrossRef
48.
Zurück zum Zitat Helbig AK, Stöckl D, Heier M, Ladwig KH, Meisinger C. Symptoms of Insomnia and Sleep Duration and Their Association with Incident Strokes: Findings from the Population-Based MONICA/KORA Augsburg Cohort Study. PLoS ONE 2015; 10(7):e0134480CrossRef Helbig AK, Stöckl D, Heier M, Ladwig KH, Meisinger C. Symptoms of Insomnia and Sleep Duration and Their Association with Incident Strokes: Findings from the Population-Based MONICA/KORA Augsburg Cohort Study. PLoS ONE 2015; 10(7):e0134480CrossRef
49.
Zurück zum Zitat Westerlund A, Bellocco R, Sundstrom J, Adami HO, Akerstedt T, Trolle Lagerros Y. Sleep characteristics and cardiovascular events in a large Swedish cohort. Eur J Epidemiol 2013; 28(6):463–73CrossRef Westerlund A, Bellocco R, Sundstrom J, Adami HO, Akerstedt T, Trolle Lagerros Y. Sleep characteristics and cardiovascular events in a large Swedish cohort. Eur J Epidemiol 2013; 28(6):463–73CrossRef
50.
Zurück zum Zitat Zhang W, Li F, Zhang T. Relationship of nocturnal concentrations of melatonin, gamma-aminobutyric acid and total antioxidants in peripheral blood with insomnia after stroke: study protocol for a prospective non-randomized controlled trial. Neural Regen Res 2017; 12(8):1299–307CrossRef Zhang W, Li F, Zhang T. Relationship of nocturnal concentrations of melatonin, gamma-aminobutyric acid and total antioxidants in peripheral blood with insomnia after stroke: study protocol for a prospective non-randomized controlled trial. Neural Regen Res 2017; 12(8):1299–307CrossRef
51.
Zurück zum Zitat Glozier N, Moullaalib TJ, Sivertsen B, Kim D, Mead G et al. The Course and Impact of Poststroke Insomnia in Stroke Survivors Aged 18 to 65 Years: Results from the Psychosocial Outcomes In StrokE (POISE) Study. Cerebrovasc Dis Extra 2017; 7:9–20CrossRef Glozier N, Moullaalib TJ, Sivertsen B, Kim D, Mead G et al. The Course and Impact of Poststroke Insomnia in Stroke Survivors Aged 18 to 65 Years: Results from the Psychosocial Outcomes In StrokE (POISE) Study. Cerebrovasc Dis Extra 2017; 7:9–20CrossRef
52.
Zurück zum Zitat Tang WK, Grace Lau C, Mok V, Ungvari GS, Wong KS. Insomnia and health-related quality of life in stroke. Top Stroke Rehabil 2015; 22(3):201–7CrossRef Tang WK, Grace Lau C, Mok V, Ungvari GS, Wong KS. Insomnia and health-related quality of life in stroke. Top Stroke Rehabil 2015; 22(3):201–7CrossRef
53.
Zurück zum Zitat Siengsukon CF, Boyd LA. Sleep to learn after stroke: implicit and explicit off-line motor learning. Neurosci Lett 2009; 451(1):1–5CrossRef Siengsukon CF, Boyd LA. Sleep to learn after stroke: implicit and explicit off-line motor learning. Neurosci Lett 2009; 451(1):1–5CrossRef
Metadaten
Titel
Schlaf-Wach-Störungen
Insomnie bei neurologischen Erkrankungen
verfasst von
Prof. Dr. med. Geert Mayer
Publikationsdatum
29.09.2018
Verlag
Springer Medizin
Erschienen in
DNP – Die Neurologie & Psychiatrie / Ausgabe 5/2018
Print ISSN: 2731-8168
Elektronische ISSN: 2731-8176
DOI
https://doi.org/10.1007/s15202-018-1884-y

Weitere Artikel der Ausgabe 5/2018

DNP - Der Neurologe & Psychiater 5/2018 Zur Ausgabe